ISRCTN88796215Completed未知
A randomised trial of adjuvant 5-fluorouracil, leucovorin and radiotherapy in colorectal adenocarcinoma
Wyeth-Lederle Ltd (UK)0 sites0 target enrollmentStarted: August 19, 2002Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Aged 18 to 80 years
- •2. World Health Organisation (WHO) performance status zero to two
- •3. Histological proof of colorectal adenocarcinoma
- •4. The entire colorectum must be visualised pre- or postoperatively to exclude synchronous carcinoma
- •5. Potentially curative surgery
- •6. Adjuvant treatment to be initiated within six weeks of surgery
- •7. Adequate bone marrow, renal and hepatic function
Exclusion Criteria
- •No previous malignancy except carcinoma in situ of cervix or basal cell carcinoma of skin
Investigators
Similar Trials
Completed
Not Applicable
A randomised trial of infusional 5-fluorouracil and concomitant radiotherapy in locally advanced rectal cancer, comparing three and six months of infusional 5-fluorouracilCancer of rectumCancerISRCTN93845533The Royal Marsden NHS Foundation Trust (UK)
Completed
Not Applicable
Phase II randomized trial comparing 5-fluorouracil in continuous infusion and cisplatin (FP) versus leucovorin, bolus 5-fluorouracil and cisplatin (FLP) in metastatic gastric, pancreatic and oesophageal cancerMetastatic gastric, pancreatic and oesophageal cancerOesophagealCancerISRCTN05842222French Federation of Digestive Cancers (Fédération Francophone de la Cancérologie Digestive [FFCD]) (France)232
Completed
Phase 2
Randomized phase II/III study of 5-fluorouracil /l-leucovorin vs. 5-fluorouracil /l-leucovorin plus paclitaxel in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G, abbreviation:GC_FL/FLTAX_P2/3)Gastric cancerJPRN-UMIN000010949Japan Clinical Oncology Group (JCOG)330
Unknown
Not Applicable
Randomized clinical trial on the efficacy of 5-fluorouracil(5-FU) ointment on the outer and middle ear cholesteatomaJPRN-UMIN000024217agasaki University hospital54
Active, not recruiting
Phase 1
Phase 1b trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treatment of patients with MGMT silenced, microsatellite stable metastatic colorectal cancer.metastatic colorectal cancerMedDRA version: 27.0Level: LLTClassification code: 10052362Term: Metastatic colorectal cancer Class: 10029104MedDRA version: 20.0Level: SOCClassification code: 10029104Term: Neoplasms benign malignant and unspecified (incl cysts and polyps) Class: 2CTIS2024-515580-64-00Fondazione IRCCS Istituto Nazionale Dei Tumori18